Educational and Interactive Evening 2024 (with Case Studies & Small Group Discussion)
Date: 4/06/2024 (AEST)
Venue: Twin Road, North Ryde, NSW, 2113
Provider: Retina Associates
Contact: Vinnci Wu, [E] vinnci@retina.com.au, [P] 0294113333
Activity Outline
Topics: Update on Central Serous Chorioretinopathy (small group discussion)
Floaters - Is it really a problem? (small group discussion)
Managing Diabetic Retinopathy in 2024 (small group discussion)
Interventional glaucoma & the role of genetic testing in glaucoma suspects (small group discussion)
Q & A (Panel discussion)
Speakers:
A/Prof Alex Hunyor, Prof I-van Ho, Dr Robert Chong and Dr Aparna Raniga.
There will be a panel discussion of various cases at the end with audience input along with an assessment.
All presentations will be presented on power point.
Learning Objectives
- Interpret and use OCT findings to differentiate between age-related macular degeneration and other masquerading conditions.
- Develop a systematic approach to the interpretation of OCT and OCT-A images.
- Understand surgical approaches utilized in the management of vitreoretinal pathology.
- To know the signs for differential diagnosis
- To work in conjunction with ophthalmologists to monitor certain eye conditions
- Learn to distinguish which are the appropriate patients to refer
- Learn to diagnose and manage diabetic retinopathy
- Understand the surgical and non-surgical approaches to the treatment of diabetic retinopathy
- To review the evidence of intervention in the management of diabetic retinopathy
- Identify risk factors crucial to the diagnosis and progression of glaucoma
- Increase awareness of alternatives to glaucoma eye drops, including the mechanism of action and the benefits and risks of these alternatives.
- Be exposed to glaucoma treatment options on the horizon – e.g., biodegradable injectable devices impregnated with IOP lowering medication
- Surgical treatment options, including discussing the emerging concept of “interventional glaucoma”
- Revise the range of intraocular pressure (IOP) lowering drops available, including becoming familiar with the side effect profile of each subset of medication
Max CPD hours awarded: 3.5
Session Information
| Name |
|---|
| Update on Central Serous Chorioretinopathy (small group discussion) |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Floaters - Is it really a problem?" (small group discussion) |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Interventional glaucoma & the role of genetic testing in glaucoma suspects (small group discussion) |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Managing Diabetic Retinopathy |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Q & A (Panel discussion) |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |